MedPath

Diphenhydramine

Generic Name
Diphenhydramine
Brand Names
Acetadryl, Advil PM, Aleve PM, Allegra Cooling Relief Anti-itch, Banophen, Benadryl, Benadryl Itch Stopping, Benadryl-D Allergy and Sinus, Calagel, Damylin With Codeine, Dimetapp Nighttime Cold & Congestion, Diphen, Diphenhist, Diphenist, Excedrin PM Triple Action, Goody's PM, Legatrin PM, Motrin PM, Nytol, Nytol Quickgels, Percogesic Reformulated Jan 2011, Siladryl, Simply Sleep, Sleepinal, Sominex, Triaminic Night Time Cold & Cough, Tylenol PM, Unisom, Unisom Sleep, Vanamine, Wal-dryl, Wal-som (doxylamine), Zzzquil
Drug Type
Small Molecule
Chemical Formula
C17H21NO
CAS Number
58-73-1
Unique Ingredient Identifier
8GTS82S83M
Background

Diphenhydramine - perhaps known most commonly as its brand name formulation Benadryl - is a first-generation H1 receptor antihistamine that is used extensively for the treatment of seasonal allergies, insect bites and stings, and rashes . However, it also has antiemetic, antitussive, hypnotic, and antiparkinson properties . As histamine receptors exist both peripherally and in the central nervous system, diphenhydramine has been shown to cause sedation due to its competitive antagonism of histamine H1 receptors within the central nervous system . While its use in allergy therapy can sometimes fall out of favor due to its sedative effect, diphenhydramine has been repurposed for use within many non-prescription over-the-counter sleep aids and cough-and-cold medications that have been marketed for "night time" use .

Diphenhydramine is also used in combination with 8-chlorotheophylline as the anti-nausea drug Dimenhydrinate where it is utilized primarily for its antagonism of H1 histamine receptors within the vestibular system .

Diphenhydramine has also been shown to be implicated in a number of neurotransmitter systems that affect behaviour including dopamine, norepinephrine, serotonin, acetylcholine, and opioid . As a result, diphenhydramine is being investigated for its anxiolytic and anti-depressant properties.

Indication

Diphenhydramine is a first-generation histamine H1 receptor antagonist (H1 antihistamine) that is widely available as a non-prescription, over-the-counter (OTC) medication. As an OTC medication, diphenhydramine is typically formulated as tablets and creams indicated for use in treating sneezing, runny nose, itchy/watery eyes, itching of nose or throat, insomnia, pruritis, urticaria, insect bites/stings, allergic rashes, and nausea .

Additionally, when the use of oral diphenhydramine is impractical, there are also prescription-only formulations such as diphenhydramine injection products that are effective in adults and pediatric patients (other than premature infants and neonates) for:

i) the amelioration of allergic reactions to blood or plasma, in anaphylaxis as an adjunct to epinephrine and other standard measures after acute allergic reaction symptoms have been controlled, and for other uncomplicated allergic conditions of the immediate type when oral therapy is impossible or contraindicated ;

ii) the active treatment of motion sickness ; and

iii) use in parkinsonism when oral therapy is impossible or contraindicated, as follows: parkinsonism in the elderly who are unable to tolerate more potent agents; mild cases of parkinsonism in other age groups, and in other cases of parkinsonism in combination with centrally acting anticholinergic agents .

Associated Conditions
Allergic Reaction, Allergic Rhinitis (AR), Allergic cough, Allergy to Tree Pollen, Anaphylaxis, Angioedema, Common Cold, Conjunctival irritation, Cough, Cough Variant Asthma, Cough caused by Common Cold, Eye allergy, Fever, Insect Bites, Insect Stings, Insomnia, Irritative cough, Itching of the nose, Itching of the throat, Motion Sickness, Nasal Congestion, Oral Mucositis, Pain, Parkinsonian Syndromes, Productive cough, Pruritus, Rash, Rhinorrhoea, Sinus Congestion, Sinus headache, Skin Irritation, Sneezing, Sunburn, Symptoms of Acute Bronchitis Accompanied by Coughing, Upper respiratory tract hypersensitivity reaction, site unspecified, Urticaria, Cold or flu syndrome, Dermatographism, Dry cough, Watery itchy eyes
Associated Therapies
Airway secretion clearance therapy, Expectorant

Impact of Temsirolimus Therapy on Circulating Tumor Cell Biology In Men With Castration Resistant Metastatic Prostate Cancer

Phase 2
Terminated
Conditions
Prostate Cancer
Interventions
First Posted Date
2009-04-24
Last Posted Date
2014-02-26
Lead Sponsor
Duke University
Target Recruit Count
11
Registration Number
NCT00887640
Locations
🇺🇸

Virginia Oncology Associates, Norfolk, Virginia, United States

🇺🇸

Duke University Medical Center, Durham, North Carolina, United States

A Study of Xolair (Omalizumab) in Patients With Chronic Idiopathic Urticaria (CIU) Who Remain Symptomatic With Antihistamine Treatment (H1)

Phase 2
Completed
Conditions
Chronic Idiopathic Urticaria
Interventions
Drug: H1 antihistamines
Drug: placebo
First Posted Date
2009-03-23
Last Posted Date
2017-07-11
Lead Sponsor
Genentech, Inc.
Target Recruit Count
90
Registration Number
NCT00866788

Multi-virus CTLs Expressing CD19 Chimeric Receptors, CD19 Positive Malignancies Post SCT, MULTIPRAT

Phase 1
Active, not recruiting
Conditions
Acute Lymphoblastic Leukemia (ALL)
Chronic Lymphocytic Leukemia (CLL)
Non Hodgkin's Lymphoma
Interventions
Genetic: CD19CAR/virus specific T cells
First Posted Date
2009-02-10
Last Posted Date
2024-07-05
Lead Sponsor
Baylor College of Medicine
Target Recruit Count
68
Registration Number
NCT00840853
Locations
🇺🇸

Houston Methodist Hospital, Houston, Texas, United States

🇺🇸

Texas Children's Hospital, Houston, Texas, United States

A Study of Single Dose Pain Therapy in Patients With Painful Diabetic Neuropathy (0000-115)

Phase 2
Withdrawn
Conditions
Painful Diabetic Neuropathy
First Posted Date
2009-02-06
Last Posted Date
2015-07-27
Lead Sponsor
Merck Sharp & Dohme LLC
Registration Number
NCT00837941

Study to Evaluate Diphenhydramine in Children and Adolescents

Phase 1
Completed
Conditions
Allergic Rhinitis
Interventions
First Posted Date
2008-09-30
Last Posted Date
2011-10-06
Lead Sponsor
Johnson & Johnson Consumer and Personal Products Worldwide
Target Recruit Count
36
Registration Number
NCT00762749
Locations
🇺🇸

Arkansas Medical Research Testing Center, Little Rock, Arkansas, United States

Metoclopramide for Migraine: A Dose Finding Study

Phase 3
Completed
Conditions
Migraine
Interventions
First Posted Date
2008-05-22
Last Posted Date
2018-05-31
Lead Sponsor
Montefiore Medical Center
Target Recruit Count
349
Registration Number
NCT00682734
Locations
🇺🇸

Montefiore Medical Center, Bronx, New York, United States

Bioequivalence Between Two Oral Formulations of Diphenhydramine Hydrochloride

Phase 1
Completed
Conditions
Nasal Congestion
Interventions
First Posted Date
2008-04-21
Last Posted Date
2011-09-08
Lead Sponsor
Johnson & Johnson Consumer and Personal Products Worldwide
Target Recruit Count
36
Registration Number
NCT00662337

To Determine if Diphenhydramine Works for Nasal Congestion at Two Different Doses

Phase 4
Completed
Conditions
Nasal Congestion
Interventions
First Posted Date
2008-04-01
Last Posted Date
2011-08-22
Lead Sponsor
Johnson & Johnson Consumer and Personal Products Worldwide
Target Recruit Count
1021
Registration Number
NCT00648973
Locations
🇺🇸

Sun Research Institute, San Antonio, Texas, United States

🇺🇸

Biogenics Research Institute, San Antonio, Texas, United States

🇺🇸

Diagnostics Research Group, San Antonio, Texas, United States

and more 9 locations

Treating Benign Paroxysmal Positional Vertigo (BPPV) in ED Patients

Not Applicable
Completed
Conditions
Benign Paroxysmal Positional Vertigo
Interventions
First Posted Date
2008-03-24
Last Posted Date
2018-04-03
Lead Sponsor
Lehigh Valley Hospital
Target Recruit Count
26
Registration Number
NCT00641797
Locations
🇺🇸

Lehigh Valley Hospital, Allentown, Pennsylvania, United States

Lumbar Stenosis Outcomes Research (LUSTOR)

Phase 4
Completed
Conditions
Lumbar Spinal Stenosis
Interventions
First Posted Date
2008-03-19
Last Posted Date
2016-06-20
Lead Sponsor
University of Rochester
Target Recruit Count
29
Registration Number
NCT00638443
Locations
🇺🇸

2180 South Clinton Avenue, Rochester, New York, United States

© Copyright 2025. All Rights Reserved by MedPath